China’s diagnostic criteria for drug-induced liver damage: (1) China’s diagnostic criteria often used before 2007 (commonly used in China), the criteria mainly include the following seven points: ① the manifestations of liver damage appear within 1 to 4 weeks after the use of medication, and a few latent period of up to a few months or longer; ② some patients with the initial symptoms of fever, rash, itching, etc.; ③ the peripheral blood eosinophils are greater than 0.06; ④ macrophages or lymphoblastoid transformation test (+); ⑤ clinical signs of liver parenchymal cell damage or intrahepatic cholestasis and (or) pathological manifestations; @HBs or lymphoblastoid transformation test (+); ⑤ clinical signs and (or) pathological manifestations of liver parenchymal cell damage or intrahepatic cholestasis; @ HBsAg, core antibody to hepatitis B virus, anti-hepatitis A virus antibody (IgM type), anti-hepatitis C virus antibody, anti-hepatitis D virus antibody, and anti-hepatitis E virus antibody are all (-); ⑦ occasional re-administration of the same drug and then liver damage occurs. The diagnosis of drug-induced liver disease can be made by the presence of ①, plus any 2 of ② – ⑦. (2) Domestic new standards In 2007, the Hepatobiliary Diseases Collaborative Group of the Division of Gastroenterology of the Chinese Medical Association summarized the information on drug-induced liver disease in many hospitals in China, and put forward the diagnostic criteria for acute drug-induced liver disease (the new domestic standards) with reference to international standards. It is divided into 3 parts: diagnostic criteria, exclusion criteria, and suspected cases. The diagnostic criteria and exclusion criteria are in the form of entries, and for suspected cases or reevaluated cases, it is recommended that the RUCAM scale be used for quantitative assessment.